Oncternal Therapeutics ONCT

$ 1.13 1.93%

Quarterly report 2024-Q3
added 11-06-2024

Oncternal Therapeutics Total Shareholders Equity 2011-2024 | ONCT

Annual Total Shareholders Equity Oncternal Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.1 M	61 M	88.1 M	113 M	14.3 M	-29.6 M	38.3 M	19.9 M	1.86 M	17.8 M	10.7 M	47.7 M	71.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
113 M	-29.6 M	37.3 M

Quarterly Total Shareholders Equity Oncternal Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9.15 M	15.8 M	22.9 M	30.1 M	37 M	45.2 M	52.5 M	61 M	68.5 M	74 M	80.2 M	88.1 M	94.5 M	103 M	108 M	113 M	113 M	113 M	113 M	14.3 M	14.3 M	14.3 M	14.3 M	-29.6 M	-29.6 M	-29.6 M	26.1 M	-23.3 M	38.3 M	38.3 M	38.3 M	19.9 M	19.9 M	19.9 M	19.9 M	1.86 M	1.86 M	1.86 M	1.86 M	17.8 M	17.8 M	17.8 M	17.8 M	10.7 M	10.7 M	10.7 M	10.7 M	47.7 M	47.7 M	47.7 M	47.7 M	71.9 M	71.9 M	71.9 M	71.9 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
113 M	-29.6 M	38.3 M